SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PODD

Insulet Corp (NASDAQ:PODD)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$133.17-$4.06 (-2.96%)
 
Market cap
$9.24B
Insider Score
Health Score
Analyst consensus
Listed since
May 15, 2007
Market Cap$9.24B-59.8%
Revenue (ttm)$3.19B+26.5%
Net Income$428.80M+74.2%
EPS$6.14+78.0%
Shares Out69.37M
PE Ratio21.65
Forward PE16.62
Dividendn/a
Ex-Dividend Daten/a
Volume1,803,655
Open$135.34
Previous Close$137.23
Day's Range$132.34 - $140.40
52-Week Range$126.40 - $342.13
Beta1.06
AnalystsBuy
Price Target$177.41(+33.22%)
Earnings DateFeb 17, 2027

About PODD

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Address
100 Nagog Park, Acton, MA, 01720, US
Market Cap
9.24 billion
Employees
5,400
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$59.89K
Bought
$1.06M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Hold
3 Buy7 Hold0 SellAvg target $204.25 (+53.4%)

10 firms rating PODD in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Strong
From PODD’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.96%
5 Days
-13.24%
1 Month
-6.15%
6 Months
-15.12%
1 Year
-59.79%

$PODD stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of PODD by members of U.S. Congress

Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KOct 20, 2026
Gilbert CisnerosHouse / DSale$1.00K – $15.00KSep 18, 2026
Ro KhannaHouse / DPurchase$1.00K – $15.00KSep 11, 2026
Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KAug 18, 2026
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KSep 17, 2019
Gilbert CisnerosHouse / DSale$1.00K – $15.00KSep 17, 2019
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KSep 16, 2019
Josh GottheimerHouse / DSale$1.00K – $15.00KSep 13, 2019

Recently reported changes in PODD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PODD's directors and management

Net Shares Purchased by Insiders−6k−3k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PODD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

PODD Revenue by Segment or Geography

PODD's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New PODD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PODD from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in PODD

VOOVanguard S&P 500 ETF$275.93M
VTIVanguard Morningstar Total Stock Market ETF$260.14M
VBVanguard Morningstar Small-Cap ETF$232.71M
RSPInvesco S&P 500 Equal Weight ETF$203.52M
VBKVanguard Morningstar Small-Cap Growth ETF$130.14M
IVViShares Core S&P 500 ETF$128.17M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from PODD’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
67.5
Analyst Ratings
32% of score
85
News & Sentiment
20% of score
35

News check: Multiple analyst downgrades (Baird to Neutral, Stifel cut after growth deceleration) outweigh valuation discussion pieces and board appointment news.

Recent Insider Activity

Buys
3
Sells
1
Buy Value
$1.06M
Distinct Buyers
3

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

PEPTREX Peptide ETF7.90%
EDOCGlobal X Telemedicine & Digital Health ETF4.64%
FDHTFIDELITY DIGITAL HEALTH ETF4.57%
BTALAGF U.S. Market Neutral Anti-Beta Fund3.93%
TMEDT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF3.59%
EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF3.30%
HEALGlobal X HealthTech ETF2.96%
FORHFormidable ETF2.11%
MDEVFirst Trust Indxx Medical Devices ETF2.07%
XHEState Street SPDR S&P Health Care Equipment ETF1.64%
RSPHInvesco S&P 500 Equal Weight Health Care ETF1.59%
RYHInvesco S&P 500 Equal Weight Health Care ETF1.59%

Weight is the stock’s share of each fund’s holdings.